This study investigated the potential protective/healing effects of curcumin, an anti-diabetic agent, on the ovary of in the early and late stages of diabetes (after seven days and 21 days, and during the development of metabolic disorder) using stereological, biochemical, and histopathological methods.
Weight loss has frequently been described among the symptoms caused by hyperglycemia (Ballester et al. 2007; Prasad et al. 2009; Garris and Garris 2004; Kim et al. 2006). Similar findings were obtained in the present study. The relative weight loss (%) in the DM group was higher than in the control, DC2, and DC3 groups. Type 1 DM generally results in a state of hypoleptinemia with mid- to long-term decreases in body weight. The adipose tissue hormone leptin participates in the integrated control of energy balance and reproductive activities. Severe hypogonadism has been observed in animals with leptin deficiency (Tena-Sempere 2007). Weight loss has also been reported to lead to loss of menstrual function, resulting in a lower LH and FSH response for GnRH. These side-effects may be reverses with weight gain (Frisch and McArthur 1974; Warren et al. 1975). In this study, the excessive weight loss in DM group rats (excessive relative weight loss) and the pronounced lipid deficiency in ovarian stroma cells along with the progression of the disease suggest that abnormalities such as angiogenesis, secretion of steroid hormones, and impaired metabolism may be caused by adipose tissue deficiency. Curcumin has been reported to increase serum adiponectin and leptin levels in patients with metabolic syndrome (Panahi et al. 2016). One study stated that 15 mg/kg curcumin administration prevented body weight loss (El-Demerdash et al. 2009). Our study findings showed that treatment with curcumin at 30 mg/kg for 14 days 21 days after induction of diabetes (DC2) and concurrently with diabetes (DC3) had a positive effect on body weight maintenance. However, this effect was not observed in the group (DC1) given curcumin seven days after induction of diabetes. This may be due to properties of curcumin such as suppressing preadipocyte differentiation in the early stages of diabetes and reducing both adipocyte numbers and fat content in adipose tissue (Ahn et al. 2010; Zhao et al. 2011).
The gonadosomatic index (GSI) in the DM group in this study decreased significantly compared to the control, sham and curcumin groups. Studies involving diabetic rats have reported that abnormalities in the HPG axis (Valdes et al. 1991), and GnRH, which regulates sexual maturation and reproductive functions in mammals, cause faster shrinkage of the Graafian follicle, resulting in a decrease in ovarian mass and thus a decrease in GSI. In addition, GnRH exerts inhibitory effects on smaller follicles, and its sustained release may directly affect folliculogenesis, as well as causing a reduction in ovarian mass and GSI (Oluwatoyin et al. 2013). The decrease in folliculogenesis rate, follicle numbers and FSH / LH levels in the present study suggest that the decrease in GSI in diabetic rats may have occurred as a result of a disruption of the HPG axis.
The GSI is an important criterion in evaluating the individual’s reproductive potential. It increased significantly in the DC1, DC2, and DC3 groups compared to the DM group. However, no significant difference was observed between the control, sham, and curcumin groups and the DC1, DC2, and DC3 groups. No previous studies have shown the protective effect of curcumin on the GSI in diabetic rats. Our study is unique from that perspective. However, more comprehensive studies are now needed on this subject.
Examination of the fasting blood glucose levels of the experimental groups revealed a significant increase in the DM group compared to the control, sham and curcumin groups. STZ is a widely used substance for experimental induction of DM in rats. A previous study reported that insulin secretion decreased and blood glucose levels increased as a result of the rapid depletion of pancreatic Langerhans islet β cells in a DM group treated with STZ (Shima et al. 2011). Fasting blood glucose decreased significantly in the DC1, DC2, and DC3 groups in the present study compared to the DM group. However, curcumin administration did not reduce blood glucose level to those of the control, sham, and curcumin groups. Curcumin has been reported to reduce blood glucose levels in diabetic rats through regulation of the polyol pathway (Nabavi et al. 2015). The blood glucose-lowering effect of curcumin has also been observed in human clinical studies of diabetic and pre-diabetic patients (Na et al. 2013). However, curcumin had no effect on blood glucose levels in individuals with normal levels at baseline. Further studies are now needed to evaluate the effects of curcumin on insulin resistance in diseases such as hyperglycemia and diabetes.
Stereological examination of the effects of diabetes on the ovary revealed a significant decrease in the numbers of primordial follicles in the DM group compared with the control group. Primordial follicle numbers increased significantly in the DC2 group compared with the DM group. A significant decrease was observed in the DC1, DC2 and DC3 groups compared with the control group, but there was no significant difference between these groups and the sham group.
Preantral follicle numbers decreased significantly in the DM group compared with the control and sham groups, but there was no difference between them and the curcumin group. No significant difference was also determined between the DC1, DC2, and DC3 groups and the DM group. Numbers of preantral follicles decreased in all these groups compared with the control group.
Antral follicle numbers in the DM group decreased significantly compared with the control and curcumin groups, but exhibited no from those of the sham group. When the protective effect of curcumin was analyzed in terms of antral follicle numbers, the number of follicles in the DC3 group increased significantly compared with the DM group. However, no difference was found between the DM group and the DC1 and DC2 groups. The number of antral follicles in the diabetes groups following curcumin administration was not as high as that in the control group, showing that curcumin was unable to normalize antral follicle numbers in the diabetes groups. Antral follicle numbers in the DC1 group decreased significantly compared with the sham group, but no difference was found between the DC2 and DC3 groups.
Total numbers of follicles in the DM group decreased significantly compared to the control, sham and curcumin groups. The numbers of follicles in the DC2 and DC3 groups exhibited a significant increase compared to the DM group. No difference was observed between the DC1 group and the DM group. However, more follicles were observed in the control group than in the diabetes groups (DC1, DC2, and DC3), while no difference was found between the total number of follicles in the sham group and the number of follicles in the DC2 and DC3 groups.
Examination of follicular numbers can provide important information about the function of the ovary, especially the relationship between folliculogenesis and the factors that regulate it (Myers et al. 2004). A reduction in the number of follicles in diabetic individuals may lead to premature depletion of the follicle pool, leading to an increased risk of premature menopause and/or reduced fertility potential. Mouse, rat, and rabbit studies have investigated the effects of diabetes on the ovary (Farhad et al. 2013; Tiwari-Pandey and Ram Sairam 2009).
In a study of Chinese hamsters, Garris (1984) found that different levels of hyperglycemic state (medium-160-350 mg / dL blood glucose and high level 350 mg / dL blood glucose) caused severe adverse effects on ovarian functions. Total numbers of primary and secondary follicles in that study decreased in the diabetic group compared to the control group. As the hyperglycemic state progressed from moderate to high, the numbers of secondary follicles continued to decrease compared with the controls, and the percentage of available viable follicles dropped dramatically (Garris 1984). The results of our study, indicating a decrease in the numbers of preantral and antral (secondary) follicles in the DM group compared with the control group, are consistent with those of Garris. The number of antral follicles is considered one of the most important markers in evaluating functional ovarian reserves, in predicting the response to gonadotropin stimulation, and in predicting infertility and menopause risk (Depmann et al. 2016). Similarly, in Farhad et al.’s (2013) stereological mouse study, the numbers of preantral follicles and antral follicles decreased, while atretic follicle numbers increased, in the diabetic group compared with the control group. The authors also reported higher cortex and medulla volumes in the diabetic group compared with the control group. The authors suggested that this might be due to the formation of cortical vessels and polycystic structures. This finding differs from the present study, in which the cortex volume decreased significantly in the diabetic group compared with the control group. This decrease in cortex volume may be attributable to the decrease in blood vessel volume in the diabetic ovary, inflammation and increases in atretic follicles, and consequent slowing or pausing of folliculogenesis. Khedr (2016) reported that the numbers of primordial, primary, secondary, tertiary and Graafian follicles in diabetic rat ovaries decreased significantly compared with the control group in a diabetes model induced with STZ. Researchers have reported that uncontrolled diabetes causes adverse biological effects by increasing oxidative stress and lipid peroxidation (Awadin et al. 2015). In that study, factors such as increased lipid peroxidation marker MDA levels in the ovaries of diabetic rats, decreased SOD, CAT, and GPx activities, and decreased gonadotropins contributed to the degeneration of follicles (Khedr 2017).
No previous studies have investigated the effects of curcumin on the diabetic ovary, although it has been reported to protect mouse, rat, and rabbit ovary cells from proapoptotic, pronecrotic and antiproliferative effects in the face of various oxidative stress factors (Tiwari-Pandey and Ram Sairam 2009). Curcumin has frequently been shown to exhibit different effects under varying stress conditions (Tiwari-Pandey and Ram Sairam 2009; Sak et al. 2013; Aktas et al. 2012). Despite the known widespread antioxidant effects of curcumin, the data obtained from the group (DC1) in which this substance was administered seven days after diabetes induction in the present study confirmed that curcumin might exhibit different effects on organs and tissues under varying stress conditions. To summarize, curcumin was protective against diabetes in the DC2 and DC3 groups due to its antioxidant properties, while it exhibited no protective properties in the DC1 group.
Although the antioxidant properties of curcumin have been proved by numerous studies, it should be remembered that it cannot completely eliminate ROS, and that its anti-inflammatory and anti-apoptotic activities may be affected by numerous factors (Sandur et al. 2007). In addition, the apoptotic process can be triggered by the Fas/FasL pathway, as well as by various signals and pathways (Cifone et al. 1995; Li and Yuan 1999). The occurrence of follicular imbalances due to hyperglycemia in the early stages of DM suggests that the antioxidant activity of curcumin is insufficient to eliminate or reduce these adverse effects caused by diabetes. The excessively increased oxidative stress and hyperglycemia that occur in the cells in the chronic period with the induction of DM may have masked the protective role of curcumin in the follicles and the general structure of the ovary. This may be due to the production of antioxidant-induced stress by disturbing the balance between antioxidants and increased reactive species.
Primordial follicles are the most resistant follicles to external factors. However, preantral follicles can easily progress to apoptosis by being more affected by environmental conditions. The reason why curcumin does not exert a protective effect on preantral follicle numbers in diabetic groups treated with curcumin is that the developing follicles are more sensitive to external factors due to their structure, at this stage. Diabetes causes a severe deterioration in the follicle, and the dose of curcumin applied may not be sufficiently strong to restore the structure.
The mechanisms by which the primordial follicles are protected and the principal mechanisms responsible for the loss of preantral and antral follicles at different stages of diabetes have recently emerged as a new research topic. The results of the present study show a pro-oxidant effect on primordial, preantral and antral follicle numbers when curcumin was administered days after the development of diabetes. However, when administered simultaneously with the development of diabetes, it affected only the antral follicles. When given 21 days after the development of diabetes, it exhibited an antioxidant effect on and protected primordial follicle numbers. Histopathological examinations at the level of light and electron microscopy showed that curcumin exhibits protective effects on the structural and functional components of the diabetic ovary. In the curcumin-treated groups, the connective tissue and blood vessels were relatively well protected, the theca follicle around the follicles exhibited a clear organization, the structure of the glassy membrane (basement membrane) was preserved, and the internal and external layers of the theca follicle were easily visible. In the diabetic groups treated with curcumin collagen fiber density / organization in the theca externa layer and the capillary network in the interna layer were smooth and rich. The structure of the zona pellucida was also preserved in these groups, the corpus luteum cells, blood vessels and the spaces between the cells exhibited a normal appearance, and the luteal cell contents were also well preserved.
Ovarian follicular volume is the best indicator of follicular growth (Yavas and Selub 2009). In the present study, ovarian follicle volumes were estimated using the Cavalieri volume estimation method. The preantral follicle volume in the DM group exhibited an extreme decrease compared to the control and curcumin groups. No difference was observed in preantral follicle volumes between the sham and the DM groups. No difference was also determined between the DC1, DC2, and DC3 groups treated with curcumin in terms of preantral follicle volume and the DM group. Finally, no difference was observed between the DM group and the other groups.
In a study using acute and chronic insulin-dependent diabetes models, the authors reported that preovulatory oocytes were significantly smaller in size compared to the control group in both models, and that the developing follicles were smaller in size and contained more apoptotic foci (Chang et al. 2005). In addition, similarly to follicle sizes, the numbers of preovulatory oocytes and corpus luteum decreased in hyperglycemic Akita mice compared to control animals (Chang et al. 2005). Researchers have suggested that abnormally low insulin, which acts as a paracrine factor to facilitate the transition from the primordial follicle to the primary follicle, may inhibit or delay follicle transitions (Kezele et al. 2002). In another study, evaluating the protective effect of Aloe vera, a plant with hypoglycemic effects, on the rat ovarian structure, the researchers found a significant reduction in secondary and tertiary follicle diameters in diabetic rats in the group with experimental diabetes induced by STZ (Shima et al. 2011). The fact that the preantral follicle volumes obtained from our stereological analysis were lower in the diabetic group compared to the control group is consistent with those studies.
Another study examining the effects of maternal diabetes reported decreased numbers and diameters of primary and preantral follicles decreased in the ovaries of offspring born to diabetic mothers (Khaksar et al. 2013). Similarly, Tatewaki et al. (1989) observed that the percentage of primary follicles, secondary follicles, and tertiary follicles decreased in diabetic mice compared with the control group, while the percentage of atretic follicles increased. According to our findings, the decrease in the preantral follicle volume in the DM group may be due to the decrease in androgen production in follicle theca cells and changes in estrogen biosynthesis. This is because the gradual increase in estrogen production correlates with the increase in follicular surface area. In other words, three-dimensional follicular growth occurs as a result of the proliferation of theca interna and externa cells on the surface of the follicle (Gore-Langton and Armstrong 1988). In addition, FSH / LH levels impaired due to diabetes may reduce the amount of estrogen released from follicular cells (Ballester et al. 2007). The absence of any difference in antral follicle volume between the groups in the present study may be due the heterogeneity of the data in the groups, due to the fact that the follicle has a large volume and / or that the coefficients of variation of the groups are high.
Dietary curcumin in rabbits has been found to increase the diameters of primary, secondary and tertiary follicles (Sirotkin et al. 2017). The absence of any difference between the diabetic group (DM) and other groups that are named DC1, DC2 and DC3, treated with curcumin in terms of preantral follicle volumes in the present study, may be due to those authors using diameter measurement (the two-dimensional approach) when evaluating follicles, whereas we used volume calculation (the three-dimensional approach) to evaluate follicle size.
Vascularization and blood flow in the ovary are indispensable for adequate growth and development of ovarian follicles, ovulation and corpus luteum formation (Behrman et al. 2001). In the present study, the blood vessel volume in the DM group was significantly lower compared with that in the control group. In our study, we think that the decrease in blood vessel volume in the ovarian tissue of the diabetes group is related to the decrease in the volume and number of developing follicles. It is thought that the decrease in ovarian stromal vascularity may lead to less delivery of gonadotropins to the granulosa cells of the developing follicles. As it is known, during follicular atresia, the interruption of oxygen support through the blood vessels in the structure can initiate atresia. Images obtained from light microscopic and transmission electron microscopic examinations also support the above findings. The presence of capillaries with partially enlarged lumens in the theca follicle, which contains blood vessels of different diameters in the structure of the ovaries of the DM group, the fact that the capillaries are filled with amorphous material, and the intercellular space between the theca cells (disruption of the normal structure) shows that diabetes adversely affects the blood vessels in the ovaries. It has been observed that there are similar structural defects in the lumens of the blood vessels in the ovarian medulla, which has loose connective tissue characteristics. The remarkable changes as follows: the presence of amorphous substance in the reticular structure in the lumen of blood vessels due to the increase in blood viscosity, the observation of many irregular protrusions on the endothelial surface facing the lumen. All these findings can be counted as one of the causes of atresia and apoptosis-related factors in follicles.
Wu et al. (2017) reported that mice in a diabetes group given a 20-week high-fat diet had low-density blood vessels in their ovaries, and that diabetes suppressed ovarian angiogenesis. Diabetes has been found to inhibit the expression of VEGF, a vital regulatory factor for angiogenesis. We attribute the decrease in blood vessel volume in diabetic group ovarian tissue in the present study to the decrease in the volume and number of developing follicles. A reduction in ovarian stromal vascularity may lead to less transmission of gonadotropins to the granulosa cells of the developing follicles.
Both clinical and experimental diabetes are known to impair endothelial-dependent vascular activity by inactivating NO (Powers et al. 1996). NO has a luteolytic effect, mediating the increase of prostaglandins in the corpus luteum (Fridén et al. 2000). Defects in the vessels that provide blood support in the corpus luteum prevent sufficient blood from reaching the luteal cells, which causes changes in progesterone secretion, resulting in insufficient luteal function in the corpus luteum (Greenwald 1989; Reynolds 1986). Corpus luteum volumes were calculated in the present study, and a significant decrease was observed in the DM group compared with the control, sham, and curcumin groups. A considerable increase was observed in the volume of the corpus luteum in the DC2 and DC3 groups compared to the DM group, while no difference was found between the DC1 group and the DM group. The corpus luteum volumes in the DC1 and DC3 groups exhibited a significant decrease compared with the control group corpus luteum. It was observed that there was no difference between the DC2 group and the Control group in terms of corpus luteum volumes.
A decrease in the volume of the corpus luteum is known to lead to a reduction in progesterone concentrations (Elbaum et al. 1975). A study in which experimental diabetes was induced with STZ (50 mg/kg) reported a decrease in the number and diameter of the corpus luteum in the diabetic group compared to the controls (Farhad et al. 2013). Apoptosis may occur in luteal cells due to hyperglycemia in the corpus luteum. In addition, the decrease in the volume of the corpus luteum may be due to reduced lipid reserves in luteal cells. It has also been suggested that curcumin can increase serum adiponectin and leptin levels in patients with metabolic syndrome (Panahi et al. 2016).
Improving the decreased lipid reserves of luteal cells by regulating plasma leptin levels with curcumin treatment may be the main mechanism involved in the preservation of corpus luteum volume. Further studies are now needed to investigate the effect of leptin levels on corpus luteum functions in diabetic individuals treated with curcumin.
The results of the present study suggest that curcumin may have protective effects on the ovary. In the present study, we found that curcumin positively promoted angiogenesis after long-term diabetes (21 days) when used concurrently with diabetes induction, although we did not expect a positive contribution to angiogenesis with curcumin administration seven days after diabetes induction. We think that this bi-directional effect of curcumin on angiogenesis is regulated by the interaction of many factors, including VEGF, MMPs and TGF-1, fibroblast growth factor (Wang & Chen, 2019). The mechanism(s) underlying the opposite effect of curcumin on angiogenesis under different diabetic conditions now need to be investigated.
Examination of the vascular structure of the DC2 and DC3 groups under light microscopy revealed that the endothelium was normal in structure and very well bonded to the basement membrane due to the protective properties of curcumin. The presence of numerous pinocytic vesicles on the surface of the endothelial cells facing the basement membrane in these groups indicates that these cells are also functionally active.
The volume of ovarian connective tissue in the DM group increased significantly compared with the control and sham groups. In addition, no significant difference was found between the DM group and the curcumin group. The increase in the DM group ovarian connective tissue volume can be attributed to the fibrotic effect and inflammation regulated by TGF-1 and NF-kB. This may be one of the reasons for an adverse impact on ovarian functions. Because these factors increase in diabetic tissues in response to AGEs or high glucose levels (Khedr 2017; Erbas et al. 2014; Park et al. 1997; Sharma et al. 1997).
The increase in the volume of connective tissue in the ovary due to excessive proliferation of fibroblasts and the accumulation of extracellular matrix is one of the main causes of ovarian dysfunction (Zhou et al. 2017). In the present study, connective tissue volume decreased significantly after curcumin administration in the DC1, DC2, and DC3 groups compared with the DM group. These results suggest that curcumin normalizes female oocyte/follicle maturation in diabetic individuals by preventing fibrosis in the ovary. In addition, the absence of a significant difference in connective tissue volumes between these three groups (DC1, DC2, and DC3) and the control, sham and curcumin groups suggest that curcumin administration normalizes the amount of connective tissue in the diabetic groups comparison with the control, sham and curcumin groups. In addition, no difference was observed between the connective tissue volumes of the control and sham groups and those of the curcumin group.
While there was no difference in ovarian cortex volumes in the DC1, DC2, and DC3 groups compared to the DM group, a significant decrease was observed in the DC1 and DC2 groups compared to the control group. The cortex volume of the DC3 group exhibited no difference compared to the control group. No statistically significant difference was also observed in medulla volumes in the DC1, DC2, and DC3 groups compared with the control and DM groups. The decrease observed in the cortex in the DC1 and DC2 groups compared to the control group was directly proportional to the decrease in follicle numbers and connective tissue volume.
Functions such as follicular growth, oocyte maturation, and estrus behavior in the ovary are regulated by the action of gonadotropins (FSH AND LH). The HPG axis has been shown to be adversely affected by diabetic conditions (Castellano et al. 2006; Castellano et al. 2009). Studies have emphasized a strong and direct relationship between insulin and FSH / LH hormones, and this was confirmed by the findings of the present study (Katayama et al. 1984; Ballester et al. 2007). Hypothalamic-pituitary dysfunction in diabetic animals is characterized by low basal FSH and LH levels (Kirchick et al. 1982; Howland and Zebrowski 1980). While this was confirmed in the present study in terms of FSH levels, no difference was found in LH levels. This may be because LH has a shorter half-life than FSH (Liu et al. 1972). Curcumin is known to exhibit phytoestrogenic effects (Bachmeier et al. 2010). It is therefore capable of regulating the endocrine function of reproduction by interacting with the endocrine system and affecting the HPG axis, and by supporting follicular development or the protection of follicles (Sirotkin and Harrath 2014; Yan et al. 2018). Curcumin has been reported to protect against proapoptotic, pronecrotic, antiproliferative and anti-oogenic effects induced by suppression of FSH receptors in mouse ovary cells (Tiwari-Pandey and Ram Sairam 2009).
Examination of the effects of curcumin treatment applied at different times of diabetes on the HPG axis revealed that serum FSH levels increased significantly in the DC1 and DC3 groups compared with the DM group, but there was no difference between these two groups when compared with the control group. No difference between the FSH levels of the DC2 group and the DM group, but a significant decrease was observed compared with the control group. Based on our findings, it may be concluded that curcumin brings FSH levels closer to normal when administered in parallel with the development of diabetes (DC3) or seven days later (DC1). Serum FSH levels could not be normalized when curcumin was used after long-term diabetes (application 21 days after the onset of diabetes). It has been suggested that impairments in the reproductive function of diabetic female rats may be partially related to the secretion of gonadotropins (Johnson and Sidman 1979) or to a decrease in the affinity or number of gonadotropin receptors in ovarian target cells (Tesone et al. 1983). The antioxidant effect of curcumin in the DC2 group may have been insufficient to prevent disorders in the affinity and / or numbers of gonadotropins; the secretion is reduced under long-term diabetic conditions. This may be due to the low dose of curcumin dose we used, or to the duration being insufficient. We think that the antioxidant effects of curcumin on serum FSH levels should now be investigated in studies focusing on dosage and duration.
Examination of serum LH levels revealed no difference between the DC1 and DC3 groups and the control, sham, curcumin, DM, or DC2 groups, while serum LH levels in the DC2 group were significantly lower than in the control, sham, and curcumin groups. We concluded that curcumin was insufficient to normalize serum LH levels under prolonged diabetic conditions (the DC2 group).
Recent studies have shown that oxidative stress may cause infertility by affecting numbers of ovarian follicles and oocytes (Tarin 1995; Tarin 1996; Miyamoto et al. 2010). In the present study, CAT activity and SOD were measured in order to determine the underlying mechanism involved in decreased primordial / preantral follicle numbers, blood vessel volumes, and corpus luteum volumes in the diabetic groups. A significant increase in CAT activity was observed in the diabetic groups compared with the control group. In another study, and consistent with our own findings, CAT enzyme activity, which catalyzes the reduction of hydroperoxides and protects mammalian cells against oxidative damage by playing a role in neutralizing ROS, was significantly higher in diabetic rats compared to controls (Qujeq and Rezvani 2007). Researchers have made a comment that increased in CAT activity with membrane protein and lipid damage is caused by an increase in free radicals. It may therefore be concluded that the antioxidant defense system increases CAT enzyme activity as a result of oxidative stress in diabetic groups.
All the findings obtained in the present study confirm that this sequence of events is interconnected. The increase in CAT enzyme activity in connection with decreased FSH values in the diabetic group in the present study shows that the increase in follicular ROS affects hormone levels, oocyte development, and follicle numbers. In that context, it may be concluded that a delicate balance exists between the synthesis and release of ovarian hormones or changes in the sensitivity of cells to hormones and antioxidant enzymes (Halliwell et al. 1992). The decrease in plasma SOD level in the diabetic groups in the present study may have occurred due to the increased oxidative stress in the ovary. A decrease in SOD levels may cause DNA damage in primordial / preantral and antral follicles, resulting in cell loss.
CAT activity and serum SOD levels were evaluated in order to investigate the effectiveness of curcumin, an antioxidant substance, against the decrease in follicle numbers caused by oxidative stress induced by diabetes and changes in ovarian structure. Accordingly, a significant decrease in CAT activity was observed in the DC2 and DC3 groups compared with the DM group, but no difference was found compared with the control group. Serum SOD levels increased significantly in the DM group compared to the DC1, DC2, and DC3 groups. These groups (DC1, DC2, and DC3) exhibited no difference compared to the control group in terms of SOD levels. The antioxidant effects of curcumin can occur through various mechanisms. One of the most important of these may be increasing the levels of intracellular antioxidants and their mRNA levels, which are adversely affected by diabetic conditions. Due to its antioxidant activity, curcumin may reduce oxidative stress-induced toxicity, which adversely affects ovarian function, by normalizing intracellular antioxidant enzymes. In one study, high oxidative stress marker levels and decreased endogenous antioxidants were observed in the ovaries of PCOS animals. The authors reported significant normalization of SOD, CAT, and GSH activities in the PCOS group with curcumin treatment (Reddy et al. 2016).
Conclusion:
The findings of the present study indicate that diabetes causes a decrease in the numbers of follicles in the ovary, follicle and corpus luteum volumes, blood vessel and ovarian cortex volumes, body weight, GSI, and serum SOD and FSH levels. In addition, diabetes causes an increase in CAT activity and connective tissue volume. Curcumin, which possesses powerful antioxidant properties, was used to eliminate this adverse manifestation caused by diabetes. The protective effect of this substance in different stages of diabetes was extensively investigated using stereological, biochemical and histopathological analyses. It may therefore be concluded that curcumin exerts its protective effects on diabetic ovaries using the following mechanisms;
-
• Regulation of the HPG axis,
-
• Preservation of the ovarian cycle and follicle numbers,
-
• Maintenance of the normal structure of the blood vessel, and
-
• Reduction of fibrosis in the ovary and lowering hyperglycemia
We suggest that curcumin exerts a protective effect by reducing fibrosis in the ovary and lowering hyperglycemia. In the light of the results of this study, it can be concluded that curcumin may be a desirable and effective substance for restoring ovarian follicle damage in individuals exposed to hyperglycemia. However, comprehensive molecular studies are now needed on this subject. In addition, it should not be forgotten that in addition to its antioxidant properties, curcumin might also have a pro-oxidant effect under some conditions.